Beijing Bohui Innovation Biotechnology Group Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 503.81 million compared to CNY 361.65 million a year ago. Revenue was CNY 526.91 million compared to CNY 383.31 million a year ago.

Net income was CNY 5.93 million compared to net loss of CNY 19.78 million a year ago. Basic earnings per share from continuing operations was CNY 0.0073 compared to basic loss per share from continuing operations of CNY 0.0242 a year ago. Diluted earnings per share from continuing operations was CNY 0.0073 compared to diluted loss per share from continuing operations of CNY 0.0242 a year ago.